These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11710729)

  • 1. Cytochrome P2 polymorphisms and susceptibility to scleroderma: comment on the article by Povey et al.
    Pandey JP; Nietert PJ; Silver RM
    Arthritis Rheum; 2001 Nov; 44(11):2705-6. PubMed ID: 11710729
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytochrome P2 polymorphisms and susceptibility to scleroderma following exposure to organic solvents.
    Povey A; Guppy MJ; Wood M; Knight C; Black CM; Silman AJ
    Arthritis Rheum; 2001 Mar; 44(3):662-5. PubMed ID: 11263781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Familial systemic sclerosis following exposure to organic solvents and the possible implication of genetic factors.
    Calvani N; Silvestris F; Dammacco F
    Ann Ital Med Int; 2001; 16(3):175-8. PubMed ID: 11692907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of a functional polymorphism in the matrix metalloproteinase-12 promoter region with systemic sclerosis in an Italian population.
    Manetti M; Ibba-Manneschi L; Fatini C; Guiducci S; Cuomo G; Bonino C; Bazzichi L; Liakouli V; Giacomelli R; Abbate R; Bombardieri S; Montecucco C; Valentini G; Matucci-Cerinic M
    J Rheumatol; 2010 Sep; 37(9):1852-7. PubMed ID: 20595276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic sclerosis: environmental factors.
    Mora GF
    J Rheumatol; 2009 Nov; 36(11):2383-96. PubMed ID: 19797508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypothesis: exposure to solvents may cause fibrosing alveolitis.
    Billings CG; Howard P
    Eur Respir J; 1994 Jun; 7(6):1172-6. PubMed ID: 7925888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme oxygenase-1 promoter polymorphisms do not influence susceptibility to systemic sclerosis and its clinical phenotypes.
    van Bon L; Broen JC; Schijvenaars MM; Rueda B; Simeón CP; Ortego-Centeno N; González-Gay MA; Radstake TR; Hunzelmann N; Riemekasten G; Witte T; Wagener FA; Vonk MC; Coenen MJ; Martin J
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):186. PubMed ID: 23406650
    [No Abstract]   [Full Text] [Related]  

  • 8. Exposure to chemicals and systemic sclerosis.
    Czirják L; Csiki Z; Nagy Z; Tóth E
    Ann Rheum Dis; 1995 Jun; 54(6):529. PubMed ID: 7632101
    [No Abstract]   [Full Text] [Related]  

  • 9. Environmental scleroderma.
    Haustein UF; Herrmann K
    Clin Dermatol; 1994; 12(3):467-73. PubMed ID: 7954204
    [No Abstract]   [Full Text] [Related]  

  • 10. [Scleroderma and environment. I. Scleroderma and sclerodermiform states induced by silica and chemical agents or drugs].
    de la Espriella J; Crickx B
    Ann Dermatol Venereol; 1991; 118(12):948-53. PubMed ID: 1724723
    [No Abstract]   [Full Text] [Related]  

  • 11. Polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in systemic sclerosis.
    Assassi S; Mayes MD; McNearney T; Fischbach M; Reveille JD; Arnett FC; Tan FK
    Am J Med; 2005 Aug; 118(8):907-11. PubMed ID: 16084185
    [No Abstract]   [Full Text] [Related]  

  • 12. Scleroderma and solvent exposure among women.
    Garabrant DH; Lacey JV; Laing TJ; Gillespie BW; Mayes MD; Cooper BC; Schottenfeld D
    Am J Epidemiol; 2003 Mar; 157(6):493-500. PubMed ID: 12631538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic sclerosis and organic solvents: early diagnosis in industry.
    Garcia-Zamalloa AM; Ojeda E; Gonzalez-Beneitez C; Goni J; Garrido A
    Ann Rheum Dis; 1994 Sep; 53(9):618. PubMed ID: 7979602
    [No Abstract]   [Full Text] [Related]  

  • 14. Generalized morphea-like scleroderma occurring in people exposed to organic solvents.
    Yamakage A; Ishikawa H
    Dermatologica; 1982 Sep; 165(3):186-93. PubMed ID: 6215270
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic and environmental factors in scleroderma.
    Welsh KI; Briggs DC
    Curr Opin Rheumatol; 1990 Dec; 2(6):920-1. PubMed ID: 2083157
    [No Abstract]   [Full Text] [Related]  

  • 16. Organic solvent exposure and systemic sclerosis: A retrospective cohort study based on the Canadian Scleroderma Research Group registry.
    Muntyanu A; Milan R; Rahme E; Baron M; Netchiporouk E;
    J Am Acad Dermatol; 2024 Mar; 90(3):605-607. PubMed ID: 37182702
    [No Abstract]   [Full Text] [Related]  

  • 17. Diffused systemic sclerosis due to occupational solvent exposure.
    Alishiri GH; Saburi A; Bayat N; Saburi E
    Rheumatol Int; 2013 Jun; 33(6):1649-50. PubMed ID: 22238027
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical significance of some genetic polymorphisms of cytochrome P-450 subfamilies CYP2D, CYP2E and CYP3A--part II].
    Wojtczak A; Skretkowicz J
    Pol Merkur Lekarski; 2009 Aug; 27(158):166-9. PubMed ID: 19856888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study on polymorphisms in metabolic enzyme genes, DNA repair genes and individual susceptibility to childhood leukemia].
    Zhu R; Xia Z
    Wei Sheng Yan Jiu; 2004 Sep; 33(5):635-8. PubMed ID: 15612500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Syndromes resembling systemic scleroderma induced by chemical agents].
    Kucharz EJ; Sierakowski SJ
    Przegl Lek; 1987; 44(9):666-71. PubMed ID: 3326053
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.